Mircea Grigorescu

1.8k total citations
47 papers, 1.3k citations indexed

About

Mircea Grigorescu is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Mircea Grigorescu has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Epidemiology, 33 papers in Hepatology and 5 papers in Surgery. Recurrent topics in Mircea Grigorescu's work include Liver Disease Diagnosis and Treatment (33 papers), Hepatitis C virus research (18 papers) and Liver Disease and Transplantation (15 papers). Mircea Grigorescu is often cited by papers focused on Liver Disease Diagnosis and Treatment (33 papers), Hepatitis C virus research (18 papers) and Liver Disease and Transplantation (15 papers). Mircea Grigorescu collaborates with scholars based in Romania, United States and France. Mircea Grigorescu's co-authors include Monica Lupșor‐Platon, Horia Ştefănescu, Anca Maniu, Radu Badea, Dana Crişan, Bogdan Procopeț, Corina Radu, Zeno Spârchez, Alexandru Șerban and Sorana C. Iancu and has published in prestigious journals such as Gastroenterology, Hepatology and Cancers.

In The Last Decade

Mircea Grigorescu

47 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mircea Grigorescu Romania 20 1.0k 871 200 97 95 47 1.3k
Hemda Schmilovitz‐Weiss Israel 17 796 0.8× 805 0.9× 276 1.4× 127 1.3× 53 0.6× 57 1.3k
Tetsuya Ichijo Japan 22 1.1k 1.1× 1.1k 1.3× 291 1.5× 136 1.4× 90 0.9× 45 1.6k
Young Eun Chon South Korea 21 1.2k 1.1× 1.1k 1.2× 206 1.0× 55 0.6× 110 1.2× 76 1.5k
Yoshitaka Takuma Japan 16 680 0.7× 699 0.8× 285 1.4× 130 1.3× 107 1.1× 31 1.0k
Matteo Garcovich Italy 19 527 0.5× 629 0.7× 288 1.4× 65 0.7× 107 1.1× 67 1.1k
Ki Tae Yoon South Korea 19 767 0.7× 744 0.9× 267 1.3× 120 1.2× 55 0.6× 77 1.2k
Leonardo de Lucca Schiavon Brazil 19 825 0.8× 753 0.9× 175 0.9× 109 1.1× 54 0.6× 99 1.2k
Antonio Ascione Italy 19 1.4k 1.4× 1.5k 1.7× 160 0.8× 105 1.1× 65 0.7× 53 1.7k
Laure Elkrief France 18 1.2k 1.1× 1.1k 1.3× 396 2.0× 142 1.5× 99 1.0× 45 1.5k
Marius Braun Israel 18 579 0.6× 559 0.6× 333 1.7× 78 0.8× 65 0.7× 47 1.1k

Countries citing papers authored by Mircea Grigorescu

Since Specialization
Citations

This map shows the geographic impact of Mircea Grigorescu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mircea Grigorescu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mircea Grigorescu more than expected).

Fields of papers citing papers by Mircea Grigorescu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mircea Grigorescu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mircea Grigorescu. The network helps show where Mircea Grigorescu may publish in the future.

Co-authorship network of co-authors of Mircea Grigorescu

This figure shows the co-authorship network connecting the top 25 collaborators of Mircea Grigorescu. A scholar is included among the top collaborators of Mircea Grigorescu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mircea Grigorescu. Mircea Grigorescu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Crăciun, Rareș, Horia Ştefănescu, Ioan Sporea, et al.. (2024). The Staging of Newly Diagnosed Hepatocellular Carcinoma in Romania. A National Multicentric Study. Journal of Gastrointestinal and Liver Diseases. 33(2). 212–217. 1 indexed citations
2.
Fischer, Petra, et al.. (2022). The threat of carbapenem resistance in Eastern Europe in patients with decompensated cirrhosis admitted to intensive care unit. Digestive and Liver Disease. 54(10). 1385–1391. 3 indexed citations
3.
Procopeț, Bogdan, Petra Fischer, Adelina Horhat, et al.. (2018). Good performance of liver stiffness measurement in the prediction of postoperative hepatic decompensation in patients with cirrhosis complicated with hepatocellular carcinoma. Medical Ultrasonography. 20(3). 272–272. 12 indexed citations
4.
Crişan, Dana, Bogdan Procopeț, Corina Radu, et al.. (2018). What’s in Metabolomics for Alcoholic Liver Disease?. Journal of Gastrointestinal and Liver Diseases. 27(1). 51–58. 14 indexed citations
5.
Crişan, Dana, et al.. (2017). Interferon-γ-inducible protein-10 in chronic hepatitis C. The Indian Journal of Medical Research. 145(4). 543–550. 5 indexed citations
6.
Procopeț, Bogdan, Mircea Vasile Cristea, Marie Angèle Robic, et al.. (2015). Serum tests, liver stiffness and artificial neural networks for diagnosing cirrhosis and portal hypertension. Digestive and Liver Disease. 47(5). 411–416. 40 indexed citations
7.
Gheorghe, Liana, Irma Eva Csiki, Speranţa Iacob, et al.. (2015). Hepatitis Delta Virus Infection in Romania: Prevalence and Risk Factors. Journal of Gastrointestinal and Liver Diseases. 24(4). 413–421. 43 indexed citations
8.
Dronca, Eleonora, Ștefan Cristian Vesa, E C Crăciun, et al.. (2014). Serum homocysteine levels, oxidative stress and cardiovascular risk in non-alcoholic steatohepatitis. European Journal of Internal Medicine. 25(8). 762–767. 64 indexed citations
9.
Procopeț, Bogdan, Christophe Bureau, Sophie Métivier, et al.. (2012). Tolerance of liver biopsy in a tertiary care center. European Journal of Gastroenterology & Hepatology. 24(10). 1209–1213. 29 indexed citations
10.
Crişan, Dana, Corina Radu, Monica Lupșor‐Platon, Zeno Spârchez, & Mircea Grigorescu. (2012). Two or More Synchronous Combination of Noninvasive Tests to Increase Accuracy of Liver Fibrosis Assessement in Chronic Hepatitis C; Results From a Cohort of 446 Patients. Hepatitis Monthly. 12(3). 177–184. 23 indexed citations
11.
Gheorghe, Liana, Speranţa Iacob, Roxana Vădan, et al.. (2011). Weight-based dosing regimen of peg-interferon α-2b for chronic hepatitis delta: a multicenter Romanian trial.. PubMed. 20(4). 377–82. 23 indexed citations
12.
Ştefănescu, Horia, Mircea Grigorescu, Monica Lupșor‐Platon, et al.. (2010). Spleen stiffness measurement using fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients. Journal of Gastroenterology and Hepatology. 26(1). 164–170. 160 indexed citations
13.
Zeuzem, Stefan, Mark Sulkowski, Eric Lawitz, et al.. (2010). Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 1. Gastroenterology. 139(4). 1257–1266. 49 indexed citations
14.
Căruntu, Florin Alexandru, Adrian Streinu‐Cercel, Liliana Gheorghe, et al.. (2009). Efficacy and safety of peginterferon alpha-2a (40KD) in HBeAg-positive chronic hepatitis B patients.. PubMed. 18(4). 425–31. 7 indexed citations
15.
Gheorghe, Liana, Speranța Iacob, Mircea Grigorescu, et al.. (2009). High sustained virological response rate to combination therapy in genotype 1 patients with histologically mild hepatitis C.. PubMed. 18(1). 51–6. 10 indexed citations
16.
Grigorescu‐Sido, Paula, et al.. (2009). Baseline characteristics and outcome in Romanian patients with Gaucher disease type 1. European Journal of Internal Medicine. 21(2). 104–113. 5 indexed citations
17.
Lupșor‐Platon, Monica, Radu Badea, Sergiu Nedevschi, et al.. (2008). Detection of steatosis in chronic hepatitis C, based on the evaluation of the attenuation coefficient computed on the ultrasound image. Medical Ultrasonography. 10(1). 13–20. 3 indexed citations
18.
Zeuzem, Stefan, Eric M. Yoshida, Yves Benhamou, et al.. (2008). Albinterferon alfa‐2b dosed every two or four weeks in interferon‐naïve patients with genotype 1 chronic hepatitis C†‡. Hepatology. 48(2). 407–417. 64 indexed citations
19.
Gheorghe, Liana, Mircea Grigorescu, Speranța Iacob, et al.. (2005). Effectiveness and tolerability of pegylated Interferon alpha-2a and ribavirin combination therapy in Romanian patients with chronic hepatitis C: from clinical trials to clinical practice.. PubMed. 14(2). 109–15. 10 indexed citations
20.
Pascu, Oliviu, et al.. (2004). Impaired health-related quality of life in Romanian patients with chronic viral hepatitis before antiviral therapy. European Journal of Gastroenterology & Hepatology. 16(1). 27–31. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hemda Schmilovitz‐Weiss Breakdown of academic impact, for papers by Tetsuya Ichijo Breakdown of academic impact, for papers by Young Eun Chon Breakdown of academic impact, for papers by Yoshitaka Takuma Breakdown of academic impact, for papers by Matteo Garcovich Breakdown of academic impact, for papers by Ki Tae Yoon Breakdown of academic impact, for papers by Leonardo de Lucca Schiavon Breakdown of academic impact, for papers by Antonio Ascione Breakdown of academic impact, for papers by Laure Elkrief Breakdown of academic impact, for papers by Marius Braun
Rankless by CCL
2026